참고문헌 (109)

1. J Clin Invest Munoz 88 1747 1991 10.1172/JCI115493 Dysregulation of in vitro cytokine production by monocytes during sepsis 

   상세보기

2. Res Commun Mol Pathol Pharmacol Kasai 98 34 1997 Anti-inflammatory cytokine levels in patients with septic shock 

   상세보기

3. Int Rev Immunol Dinarello 16 457 1998 10.3109/08830189809043005 Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist 

   상세보기

4. Nat Med Do¨cke 3 678 1997 10.1038/nm0697-678 Monocyte deactivation in septic patients: restoration by interferon gamma treatment 

   상세보기

5. Lancet Westendorp 349 170 1997 10.1016/S0140-6736(96)06413-6 Genetic influence on cytokine production in fatal meningococcal disease 

   상세보기

6. Ann Intern Med Donnelly 125 191 1996 10.7326/0003-4819-125-3-199608010-00005 The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fields of patients with the adult respiratory distress syndrome 

   상세보기

7. J Infect Dis Opal 173 1415 1996 10.1093/infdis/173.6.1415 Potential hazards of combination immunotherapy in the treatment of experimental sepsis 

   상세보기

8. Clin Microbiol Infect van de Poll 3 605 1997 10.1111/j.1469-0691.1997.tb00465.x The role of interleukin-10 in the pathogenesis of bacterial infection 

   상세보기

9. J Immunol Mosmann 136 2348 1986 10.4049/jimmunol.136.7.2348 Two types of murine helper T-cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins 

   상세보기

10. Immunol Today Kelso 16 374 1995 10.1016/0167-5699(95)80004-2 Th1 and Th2 subsets: paradigms lost? 

    상세보기

11. Crit Care Med Zedler 27 66 1999 10.1097/00003246-199901000-00028 T-cell reactivity and its predictive role in immunosuppression after burns 

    상세보기

12. Blood Dinarello 87 2095 1996 10.1182/blood.V87.6.2095.bloodjournal8762095 Biologic basis for interleukin-1 in disease 

    상세보기

13. Opal 196 1996 Therapeutic modulation of the cytokines Interleukin-1 receptor antagonist in sepsis 

14. Semin Oncol Dinarello 24 suppl S9 1997 Induction of interleukin-1 and interleukin-1 receptor antagonist 

15. Proc Natl Acad Sci USA Simms 90 6155 1993 10.1073/pnas.90.13.6155 Interleukin-1 signaling occurs exclusively via type 1 receptor 

    상세보기

16. J Biol Chem Greenfeder 270 13757 1995 10.1074/jbc.270.23.13757 Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex 

    상세보기

17. Nature Schreuder 386 194 1997 10.1038/386194a0 A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist 

    상세보기

18. Clin Exp Immunol Danis 99 303 1995 10.1111/j.1365-2249.1995.tb05549.x Cytokine production by normal human monocytes: inter-subject variation and relationship to an interleukin-1 receptor antagonist (IL-1ra) gene polymorphism 

    상세보기

19. Lancet Miller 341 146 1993 10.1016/0140-6736(93)90006-3 Balance of synovial fluid, IL-1 β and IL-1 receptor antagonist in recovery from Lyme arthritis 

    상세보기

20. J Exp Med Wilkinson 189 1863 1999 10.1084/jem.189.12.1863 Influence of polymorphism in the genes of interleukin-1 receptor antagonist and IL-1β on tuberculosis 

    상세보기

21. Crit Care Med Fang 27 1330 1999 10.1097/00003246-199907000-00024 Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis 

    상세보기

22. J Infect Dis Russel 171 1528 1995 10.1093/infdis/171.6.1528 Combined inhibition of interleukin-1 in tumor necrosis factor in rodent endotoxemia: improved survival and organ function 

    상세보기

23. Infect Immun Aiura 61 3342 1993 10.1128/IAI.61.8.3342-3350.1993 Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis -induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits 

    상세보기

24. Crit Care Med Opal 25 1115 1997 10.1097/00003246-199707000-00010 Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III randomized, double-blind, placebo-controlled multicenter trial 

    상세보기

25. Arthritis Rheum Bresnihan 41 2196 1998 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2 Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist 

    상세보기

26. Crit Rev Immunol Brown 17 1 1997 10.1615/CritRevImmunol.v17.i1.10 Functions of IL-4 and control of its expression 

    상세보기

27. J Biol Chem Wang 9558 1995 10.1074/jbc.270.16.9558 Interleukin (IL)-10 inhibits nuclear factor κB (NF-κB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms 

    상세보기

28. Blood te Velde 76 1392 1990 10.1182/blood.V76.7.1392.1392 Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α, and human IL-6 by human monocytes 

    상세보기

29. Blood Paul 77 1859 1991 10.1182/blood.V77.9.1859.1859 Interleukin-4: a prototypic immunoregulatory lymphokine 

    상세보기

30. Proc Natl Acad Sci USA Vannier 89 4076 1992 10.1073/pnas.89.9.4076 Coordinated anti-inflammatory effects of interleukin4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist 

    상세보기

31. Proc Natl Acad Sci USA Hart 86 3803 1989 10.1073/pnas.86.10.3803 Potential anti-inflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2 

    상세보기

32. Infect Immun Jain-Vora 66 4229 1998 10.1128/IAI.66.9.4229-4236.1998 Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa 

    상세보기

33. J Immunol Hultgren 160 5082 1998 10.4049/jimmunol.160.10.5082 Staphylococcus aureus -induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth 

    상세보기

34. Biochem Biophys Res Commun Toi 174 1287 1991 10.1016/0006-291X(91)91561-P Interleukin-4 is a potent mitogen for capillary endothelium 

    상세보기

35. Science Tepper 257 548 1992 10.1126/science.1636093 An eosinophil-dependent mechanism of the antitumor effect of IL-4 

    상세보기

36. Cancer Res Toi 52 275 1992 Inhibition of colon and breast carcinoma cell growth by interleukin-4 

    상세보기

37. Cancer J Sci Am Vokes 4 46 1998 A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer 

38. Clin Immunol Immunopathol Barton 85 16 1997 10.1006/clin.1997.4420 IL-6: insights into novel biological activities 

    상세보기

39. Infect Immun Barton 64 714 1996 10.1128/IAI.64.3.714-718.1996 Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model 

    상세보기

40. Eur J Immunol Libert 24 2237 1994 10.1002/eji.1830240945 Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality 

    상세보기

41. J Clin Invest Xing 101 311 1998 10.1172/JCI1368 IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses 

    상세보기

42. J Exp Med Ruzek 185 1185 1997 10.1084/jem.185.7.1185 Characterization of early cytokine responses in an interleukin-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection 

    상세보기

43. Blood Tilg 83 113 1994 10.1182/blood.V83.1.113.113 Interleukin-6 as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 

    상세보기

44. Ann Allergy Lalani 79 469 1997 10.1016/S1081-1206(10)63052-9 Interleukin-10: biology, role in inflammation and autoimmunity 

    상세보기

45. Immunol Today Howard 13 198 1992 10.1016/0167-5699(92)90153-X Biological properties of interleukin-10 

    상세보기

46. Clin Infect Dis Opal 27 1497 1998 10.1086/515032 Interleukin-10: potential benefits and possible risks in clinical infectious diseases 

    상세보기

47. J Exp Med Brandtzaeg 184 51 1996 10.1084/jem.184.1.51 Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes 

    상세보기

48. Eur J Immunol Clarke 28 1719 1998 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q IL-10 mediated suppression of TNF-α production is independent of its ability to inhibit NF-κB activity 

    상세보기

49. J Exp Med Gérard 177 547 1993 10.1084/jem.177.2.547 Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia 

    상세보기

50. Eur J Immunol Marchant 24 1167 1994 10.1002/eji.1830240524 Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia 

    상세보기

51. Blood Dickensheets 90 4162 1997 10.1182/blood.V90.10.4162 Interleukin-10 upregulates tumor necrosis factor receptor type II (p75) gene expression in endotoxin-stimulated human monocytes 

    상세보기

52. Eur J Immunol Joyce 24 2699 1994 10.1002/eji.1830241119 Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes 

    상세보기

53. Lancet Marchant 343 707 1994 10.1016/S0140-6736(94)91584-9 Interleukin-10 production during septicaemia 

    상세보기

54. J Infect Dis van der Poll 175 118 1997 10.1093/infdis/175.1.118 Anti-inflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13 

    상세보기

55. Infect Immun Lehmann 63 2109 1995 10.1128/IAI.63.6.2109-2112.1995 High levels of interleukin-10 in serum are associated with fatality in meningococcal disease 

    상세보기

56. Lancet Westendorp 349 170 1997 10.1016/S0140-6736(96)06413-6 Genetic influence on cytokine production in fatal meningococcal disease 

    상세보기

57. Lancet van Dissel 351 950 1998 10.1016/S0140-6736(05)60606-X Anti-inflammatory cytokine profile and mortality in febrile patients 

    상세보기

58. J Immunol Pajkart 158 3971 1997 10.4049/jimmunol.158.8.3971 Attenuation of pro-inflammatory response by recombinant human IL-10 in human endotoxemia: the effect of timing of rhIL-10 administration 

    상세보기

59. J Immunol Dai 158 2259 1997 10.4049/jimmunol.158.5.2259 Both innate and acquired immunity to Listeria monocytogenes infections are increased in IL-10-deficient mice 

    상세보기

60. J Infect Dis van der Poll 174 994 1996 10.1093/infdis/174.5.994 Interleukin-10 impairs host defense in murine pneumococcal pneumonia 

    상세보기

61. J Immunol Greenberger 155 722 1995 10.4049/jimmunol.155.2.722 Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia 

    상세보기

62. Cell Ku¨hn 75 263 1993 10.1016/0092-8674(93)80068-P Interleukin-10-deficient mice develop chronic enterocolitis 

    상세보기

63. Blood Du 83 2023 1994 10.1182/blood.V83.8.2023.2023 Interleukin-11: a multifunctional growth factor derived from the hematopoietic micro-environment 

    상세보기

64. J Biol Chem Neddermann 271 30986 1996 10.1074/jbc.271.48.30986 Functional expression of soluble interleukin-11 (IL-11) receptor α and stoichiometry of in vitro IL-11 receptor complexes with GP130 

    상세보기

65. Blood Tepler 87 3607 1996 A randomized-placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy 

    상세보기

66. J Immunol Trepicchio 159 5661 1997 10.4049/jimmunol.159.11.5661 Interleukin-11 regulates macrophage effector function through the inhibition of nuclear factor-κB 

    상세보기

67. J Clin Invest Hill 201 115 1998 10.1172/JCI3132 Interleukin-11 promotes T cell polarization and prevents acute graft-vs-host disease after allogeneic bone marrow transplantation 

    상세보기

68. Arthritis Rheum Hermann 41 1388 1998 10.1002/1529-0131(199808)41:8<1388::AID-ART7>3.0.CO;2-F Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis 

    상세보기

69. J Immunol de Waal Malefyt 151 6370 1993 10.4049/jimmunol.151.11.6370 Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes 

    상세보기

70. Immunol Today Zurawski 15 19 1994 10.1016/0167-5699(94)90021-3 Interleukin 13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells 

    상세보기

71. J Immunol McKenzie 150 5436 1993 10.4049/jimmunol.150.12.5436 Structural comparison and chromosomal localization of the human and mouse IL-13 genes 

    상세보기

72. Immunol Today Callard 17 108 1996 10.1016/0167-5699(96)80600-1 IL-4 and IL-13 receptors: are they one and the same? 

    상세보기

73. J Biol Chem Mijatovic 272 14394 1997 10.1074/jbc.272.22.14394 Interleukin-4 and -13 inhibit tumor necrosis factor-α mRNA translational activation in lipopolysaccharide-induced mouse macrophages 

    상세보기

74. J Immunol Di Santo 159 379 1997 10.4049/jimmunol.159.1.379 IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice 

    상세보기

75. J Immunol Muchamuel 158 2898 1997 10.4049/jimmunol.158.6.2898 IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-α, IFN-γ, and IL-12 production 

    상세보기

76. J Immunol Mulligan 159 3483 1997 10.4049/jimmunol.159.7.3483 Protective effects of IL- 4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12 

    상세보기

77. Am J Pathol Lentsch 152 1327 1998 NF-κB activation during IgG immune complex-induced lung injury: requirements for TNF-α and IL-1β but not complement 

78. J Immunol Lentsch 162 1071 1999 10.4049/jimmunol.162.2.1071 Regulation of acute lung inflammatory injury by endogenous IL-13 

    상세보기

79. Cancer Treat Rev Norgaard 21 367 1995 10.1016/0305-7372(95)90038-1 Transforming growth factor β and cancer 

    상세보기

80. Genes Dev Kingsley 8 133 1994 10.1101/gad.8.2.133 The TGF-βsuperfamily: new members, new receptors and new genetic tests of function in different organisms 

    상세보기

81. Clin Immunol Immunopathol Litterio 84 244 1997 10.1006/clin.1997.4409 TGF-β: a critical modulator of immune cell function 

    상세보기

82. Mol Reprod Dev Roberts 32 91 1992 10.1002/mrd.1080320203 Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues 

    상세보기

83. Br J Cancer Norgaard 69 802 1994 10.1038/bjc.1994.158 Growth suppression by transforming growth factor-β1 of human small cell lung cancer cell lines is associated to expression of the type II receptor 

    상세보기

84. Exp Cell Res Jetten 167 539 1986 10.1016/0014-4827(86)90193-X Regulation and proliferation and differentiation of respiratory tract epithelial cells by TGF-β 

    상세보기

85. Am J Respir Cell Mol Biol Santana 13 34 1995 10.1165/ajrcmb.13.1.7541221 Increased expression of transforming growth factor β isoforms (β1, β2, β3) in bleomycin-induced pulmonary fibrosis 

    상세보기

86. Recent Prog Horm Res Roberts 44 157 1988 Transforming growth factor-β biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis 

87. Nature Shull 359 693 1992 10.1038/359693a0 Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease 

    상세보기

88. J Infect Dis van der Poll 168 955 1993 10.1093/infdis/168.4.955 Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia 

    상세보기

89. Arch Surg Ertel 129 1330 1994 10.1001/archsurg.1994.01420360120017 Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis 

    상세보기

90. Clin Infect Dis van Deuren 26 918 1998 10.1086/513933 Plasma patterns of tumor necrosis factor-α and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange 

    상세보기

91. J Immunol Mohler 151 1548 1993 10.4049/jimmunol.151.3.1548 Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists 

    상세보기

92. J Exp Med Evans 180 2173 1994 10.1084/jem.180.6.2173 Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animals model of Gram-negative sepsis 

    상세보기

93. Proc Natl Acad Sci USA Van Zee 89 4845 1992 10.1073/pnas.89.11.4845 Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factorα in vitro and in vivo 

    상세보기

94. FEBS Lett Aizawa 445 338 1999 10.1016/S0014-5793(99)00148-9 Cloning and expression of interleukin-18 binding protein 

    상세보기

95. J Immunol Yoshimoto 161 3400 1998 10.4049/jimmunol.161.7.3400 IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production 

    상세보기

96. J Interferon Cytokine Res Thomassen 18 1077 1998 10.1089/jir.1998.18.1077 Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrpl leads to activation of signaling pathways similar to those used by interleukin-1 

    상세보기

97. J Immunol Hoshino 62 5041 1999 10.4049/jimmunol.162.9.5041 Cutting edge: generation of IL-18 receptor-deficient mice; evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor 

    상세보기

98. J Exp Med Kanakaraj 189 1129 1999 10.1084/jem.189.7.1129 Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice 

    상세보기

99. Annu Rev Immunol Spriggs 14 101 1996 10.1146/annurev.immunol.14.1.101 One step ahead of the game: viral immunomodulatory molecules 

    상세보기

100. Science Ploegh 280 248 1998 10.1126/science.280.5361.248 Viral strategies of immune evasion 

     상세보기

101. Science Moore 248 1230 1990 10.1126/science.2161559 Homology of cytokine synthesis inhibitory factor (IL-10) to Epstein-Barr virus gene BCRF1 

     상세보기

102. Infect Immun Wilson 66 2401 1998 10.1128/IAI.66.6.2401-2409.1998 Bacterial perturbation of cytokine networks 

     상세보기

103. JAMA Goldie 274 172 1995 10.1001/jama.1995.03530020090038 Natural cytokine antagonists and endogenous anti-endotoxin core antibodies in sepsis syndrome 

     상세보기

104. Immunology Girardin 76 20 1992 Imbalance between tumor necrosis factor-α and soluble TNF receptor concentration in severe meningococcaemia 

105. Crit Care Med Stu¨ber 24 381 1996 10.1097/00003246-199603000-00004 A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis 

     상세보기

106. JAMA Mira 282 561 1999 10.1001/jama.282.6.561 Association of TNF2, a TNF-α promotor polymorphism, with septic shock susceptibility and mortality: a multicenter study 

     상세보기

107. J Clin Invest Dorman 101 2364 1998 10.1172/JCI2901 Mutation in the signal-transducing chain of the interferon gamma receptor has susceptibility to mycobacterial infection 

     상세보기

108. Science Jong 280 1435 1998 10.1126/science.280.5368.1435 Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients 

     상세보기

109. N Engl J Med Moreland 337 141 1997 10.1056/NEJM199707173370301 Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein 

     상세보기